Back to Search
Start Over
C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings
- Source :
- PloS one, vol 10, iss 2, PLoS ONE, Vol 10, Iss 2, p e0117424 (2015), Tenforde, MW; Gupte, N; Dowdy, DW; Asmuth, DM; Balagopal, A; Pollard, RB; et al.(2015). C-Reactive Protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS ONE, 10(2). doi: 10.1371/journal.pone.0117424. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/6537n99x, PLoS ONE
- Publication Year :
- 2015
- Publisher :
- Public Library of Science (PLoS), 2015.
-
Abstract
- Author(s): Tenforde, Mark W; Gupte, Nikhil; Dowdy, David W; Asmuth, David M; Balagopal, Ashwin; Pollard, Richard B; Sugandhavesa, Patcharaphan; Lama, Javier R; Pillay, Sandy; Cardoso, Sandra W; Pawar, Jyoti; Santos, Breno; Riviere, Cynthia; Mwelase, Noluthando; Kanyama, Cecilia; Kumwenda, Johnstone; Hakim, James G; Kumarasamy, Nagalingeswaran; Bollinger, Robert; Semba, Richard D; Campbell, Thomas B; Gupta, Amita; ACTG PEARLS and NWCS 319 Study Group | Abstract: ObjectiveThe association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain.DesignNested case-control study (n = 332) within ACTG PEARLS trial of three ART regimens among 1571 HIV-infected, treatment-naive adults in 9 countries. We compared cases (participants with incident TB diagnosed by 96 weeks) to a random sample of controls (participants who did not develop TB, stratified by country and treatment arm).MethodsWe measured pre-ART C-reactive protein (CRP), EndoCab IgM, ferritin, interferon gamma (IFN-γ), interleukin 6 (IL-6), interferon gamma-inducible protein 10 (IP-10), lipopolysaccharide (LPS), soluble CD14 (sCD14), tumor necrosis factor alpha (TNF-α), and CD4/DR+/38+ and CD8/DR+/38+ T cells. Markers were defined according to established cutoff definitions when available, 75th percentile of measured values when not, and detectable versus undetectable for LPS. Using logistic regression, we measured associations between biomarkers and incident TB, adjusting for age, sex, study site, treatment arm, baseline CD4 and log10 viral load. We assessed the discriminatory value of biomarkers using receiver operating characteristic (ROC) analysis.ResultsSeventy-seven persons (4.9%) developed incident TB during follow-up. Elevated baseline CRP (aOR 3.25, 95% CI: 1.55-6.81) and IP-10 (aOR 1.89, 95% CI: 1.05-3.39), detectable plasma LPS (aOR 2.39, 95% CI: 1.13-5.06), and the established TB risk factors anemia and hypoalbuminemia were independently associated with incident TB. In ROC analysis, CRP, albumin, and LPS improved discrimination only modestly for TB risk when added to baseline routine patient characteristics including CD4 count, body mass index, and prior TB.ConclusionIncident TB occurs commonly after ART initiation. Although associated with higher post-ART TB risk, baseline CRP, IP-10, and LPS add limited value to routine patient characteristics in discriminating who develops active TB. Besides determining ideal cutoffs for these biomarkers, additional biomarkers should be sought that predict TB disease in ART initiators.
- Subjects :
- Lipopolysaccharides
Male
lcsh:Medicine
Gastroenterology
Hypoalbuminemia
lcsh:Science
2. Zero hunger
Multidisciplinary
biology
Incidence
Multi-drug-resistant tuberculosis
3. Good health
C-Reactive Protein
Infectious Diseases
Anti-Retroviral Agents
6.1 Pharmaceuticals
HIV/AIDS
Female
Infection
Viral load
Research Article
Risk
Adult
medicine.medical_specialty
Tuberculosis
General Science & Technology
Anemia
ACTG PEARLS and NWCS 319 Study Group
Rare Diseases
Clinical Research
Internal medicine
medicine
Humans
Developing Countries
History of tuberculosis
AIDS-Related Opportunistic Infections
business.industry
Prevention
lcsh:R
C-reactive protein
Evaluation of treatments and therapeutic interventions
medicine.disease
Chemokine CXCL10
Good Health and Well Being
Immunology
biology.protein
lcsh:Q
business
Body mass index
Subjects
Details
- ISSN :
- 19326203
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- PLOS ONE
- Accession number :
- edsair.doi.dedup.....cf192830209b6c00b00f324eedabe2d6
- Full Text :
- https://doi.org/10.1371/journal.pone.0117424